Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Sherbrooke Capital
AddedFeb 15, 2024
UpdatedJun 28, 2026
Sherbrooke Capital

Sherbrooke Capital

Operating

Sherbrooke Capital, L.L.C.: A private equity firm investing in health, wellness, and green living sectors.

Location
Newton, MA, US
Founded
1999
Firm
Compare
Portfolio
Employees

Sherbrooke Capital, L.L.C. is a private equity firm specializing in growth and expansion investments within the health and wellness industry. The firm targets companies that focus on organic food and beverages, nutrition, medical devices, personal and animal care, and green living. Sherbrooke Capital participates in various investment stages, including Seed, Series A through E, with a portfolio that reflects a diverse range of investment rounds.

Notable portfolio companies include Advanced Bionutrition, which has raised $17.1 million, and TransMedics, with $118.85 million raised. Sherbrooke Capital's investment philosophy centers on supporting innovative companies that promote healthier lifestyles and sustainable practices. The firm offers strategic guidance and industry expertise to its portfolio companies, leveraging the experience of its key partners and decision-makers to drive growth and success in the competitive health and wellness market.

Sherbrooke Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments9
Current Portfolio Count4
Total Portfolio Exits0

Top Investment Stages

Series B2 (28.6%)
Series Unknown2 (28.6%)
Seed1 (14.3%)
Series A1 (14.3%)
Series C1 (14.3%)

Stage Mix

Series B 29%Series Unknown 29%Seed 14%Series A 14%Series C 14%

Concentration shown as share of disclosed investments by stage.

Recent Investments

TransMedics logo

TransMedics

Kill Cliff logo

Kill Cliff

Advanced Bionutrition logo

Advanced Bionutrition

Boathouse Sports logo

Boathouse Sports

Sherbrooke Capital - Similar Investment Firms

Spruce Capital Partners logo

Spruce Capital Partners

sprucecp.com

Brook Venture Partners logo

Brook Venture Partners

brookventure.com

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Shamrock Capital Advisors logo

Shamrock Capital Advisors

shamrockcap.com

Bpea logo

Bpea

bpea-pe.com

Brookline Venture Partners logo

Brookline Venture Partners

Shangbay Capital logo

Shangbay Capital

Sherwood Ventures logo

Sherwood Ventures

Semcap logo

Semcap

semcap.com

Shields Capital logo

Shields Capital

Bruckmann Rosser Sherrill logo

Bruckmann Rosser Sherrill

brs.com

Schooner Capital logo

Schooner Capital

HealthQuest Capital logo

HealthQuest Capital

Brookside Equity Partners logo

Brookside Equity Partners

Amicus Capital Partners logo

Amicus Capital Partners

Sherbrooke Capital - Classification

Also Known As
  • Sherbrooke Capital II, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end